Amanote Research
Register
Sign In
Human Medicines European Public Assessment Report (EPAR): Ivabradine Anpharm, Ivabradine, Angina Pectoris,Heart Failure, Date of Authorisation: 08/09/2015, Revision: 4, Status: Authorised
Case Medical Research
doi 10.31525/cmr-c3f2a8
Full Text
Open PDF
Abstract
Available in
full text
Date
February 25, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Human Medicines European Public Assessment Report (EPAR): Ivabradine JensonR, Ivabradine, Angina Pectoris,Heart Failure, Date of Authorisation: 11/11/2016, Status: Withdrawn
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Odomzo, Sonidegib, Carcinoma, Basal Cell, Date of Authorisation: 14/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Pregabalin Accord, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Palonosetron Hospira, Palonosetron, Nausea,Vomiting,Cancer, Date of Authorisation: 08/04/2016, Revision: 4, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Duloxetine Lilly, Duloxetine, Neuralgia,Diabetic Neuropathies, Date of Authorisation: 08/12/2014, Revision: 4, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Ventavis, Iloprost, Hypertension, Pulmonary, Date of Authorisation: 15/09/2003, Revision: 26, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Entecavir Mylan, Entecavir, Hepatitis B, Date of Authorisation: 18/09/2017, Revision: 1, Status: Authorised
Case Medical Research
